High Colchicine Doses Are Really Silver Bullets Against COVID-19
Abstract The numerous attempts to prove a therapeutic effect of low-dose colchicine for the treatment of Coronavirus disease-2019 (COVID-19) have been discouraging. Increase of doses, however, leads to accumulation in leukocytes and inhibition of the cytokine storm thus preventing COVID-19 complications and hospitalizations. Hospital mortality drops up to 7-fold, while outpatients practically do not reach hospitalization.
Authors
- Vanio Mitev (ORCID: https://orcid.org/0000-0001-7528-590X)
Institutions
- Medical University of Sofia (BG)
Publication Details
- Journal
- Acta Medica Bulgarica
- Published
- 2024-11-23
- DOI
- https://doi.org/10.2478/amb-2024-0085
- Citations
- 2
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.78
Funders
- European Commission